Xencor Inc (XNCR)
19.02
+0.65
(+3.54%)
USD |
NASDAQ |
Apr 24, 16:00
19.04
+0.02
(+0.08%)
After-Hours: 20:00
Xencor Total Assets (Quarterly): 952.69M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 952.69M |
| September 30, 2023 | 778.43M |
| June 30, 2023 | 778.12M |
| March 31, 2023 | 803.41M |
| December 31, 2022 | 846.27M |
| September 30, 2022 | 835.27M |
| June 30, 2022 | 851.32M |
| March 31, 2022 | 857.92M |
| December 31, 2021 | 838.21M |
| September 30, 2021 | 697.26M |
| June 30, 2021 | 695.60M |
| March 31, 2021 | 692.74M |
| December 31, 2020 | 703.24M |
| September 30, 2020 | 646.35M |
| June 30, 2020 | 644.72M |
| March 31, 2020 | 666.96M |
| December 31, 2019 | 670.25M |
| September 30, 2019 | 686.24M |
| June 30, 2019 | 684.75M |
| March 31, 2019 | 697.00M |
| December 31, 2018 | 576.73M |
| September 30, 2018 | 585.59M |
| Date | Value |
|---|---|
| June 30, 2018 | 591.46M |
| March 31, 2018 | 612.27M |
| December 31, 2017 | 390.20M |
| September 30, 2017 | 398.26M |
| June 30, 2017 | 416.16M |
| March 31, 2017 | 418.30M |
| December 31, 2016 | 428.56M |
| September 30, 2016 | 322.13M |
| June 30, 2016 | 334.28M |
| March 31, 2016 | 193.96M |
| December 31, 2015 | 206.91M |
| September 30, 2015 | 211.48M |
| June 30, 2015 | 172.56M |
| March 31, 2015 | 178.64M |
| December 31, 2014 | 67.82M |
| September 30, 2014 | 70.87M |
| June 30, 2014 | 76.37M |
| March 31, 2014 | 82.50M |
| December 31, 2013 | 87.32M |
| September 30, 2013 | 20.21M |
| June 30, 2013 | 21.33M |
| December 31, 2012 | 11.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
644.72M
Minimum
Jun 2020
952.69M
Maximum
Dec 2023
754.20M
Average
703.24M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.990B |
| Karyopharm Therapeutics Inc | 240.44M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 283.56M |
| Shareholders Equity (Quarterly) | 668.80M |
| Debt to Equity Ratio | 0.0314 |
| Current Ratio | 7.356 |
| Net Debt Paydown Yield | -0.32% |